← Leaderboards
Neeta Pandit Taskar
Sloan-Kettering Inst Can Research
$981,974
Attributed
$1,575,429
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $784.8K · FY2017–19$1M$750K$500K$250K$0
'17
'18
'19
Funding mix
By agency
NIH$1,575,429 · 2
By mechanism
R01$1,575,429 · 2
Top collaborators
- Michael I D'Angelica2 shared
- Jason S Lewis2 shared
- Wolfgang Weber2 shared
Most similar at Sloan-Kettering Inst Can Research
Same institution · by research overlap
- Brian Matthew Zeglis$6,881,872
- John Thomas Poirier$4,490,380
- Jason S Lewis$26,024,327
- Edwin Charles Pratt$687,237
- Simone Krebs$3,266,625
Others in their field
Other Emerging Leaders on “Monitor”
- Bambra Strokes · Ppd Development Lp$461,655,950
- Kimberly Smith · Ppd Development Lp$116,656,661
- Yunda Huang · Fred Hutchinson Cancer Center$71,488,059
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,439,892
- Martha Hering · Westat, Inc.$57,098,843
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
Research focus
MonitorX-Ray Computed TomographyIsotopesModalityResolutionUptakeDoseImageMagnetic Resonance ImagingMemorial Sloan-Kettering Cancer CenterPositron-Emission TomographyResearch Clinical TestingStagingTumorDetectionDiagnosisFollow-UpHourLabelLesionMalignant NeoplasmsClinicPhase I Clinical TrialsBlood
Grant awards (4)
Histopathologic validation of 89Zr-DFO-HuMab-5B1 PET/CT imaging in CA 19-9 positive pancreatic cancer$398,509
R01 · FY2019 · CA · contact PI
Histopathologic validation of 89Zr-DFO-HuMab-5B1 PET/CT imaging in CA 19-9 positive pancreatic cancer$392,764
R01 · FY2018 · CA · contact PI
A First-in-Human Pilot Study of 18F-MFBG Imaging for Evaluation of Neuroblastoma$392,078
R01 · FY2018 · CA · contact PI
A First-in-Human Pilot Study of 18F-MFBG Imaging for Evaluation of Neuroblastoma$392,078
R01 · FY2017 · CA · contact PI